Article citationsMore>>

Fruzzetti, F., Lello, S., Lazzarini, V., et al. (2007) The oral contraceptive containing 30 microg of ethinylestradiol plus 3 mg of drospirenone is able to antagonize the increase of extracellular water occurring in healthy young women during the luteal phase of the menstrual cycle: An observational study. Contraception, 75, 199-203. doi:10.1016/j.contraception.2006.10.011

has been cited by the following article:

• TITLE: A drospirenone-containing oral contraceptive improved bleeding pattern and personal satisfaction in 914 women from Jordan, Lebanon and Syria

  AUTHORS: Ramzi Finan, Abeer Wasfi Annab, Salwa Abdalla, Farid Bedran, Mazen El-Zibdeh, Lina Shahen, Christoph Gerlinger, Erich Solomayer, Kubilay Ertan, Jan Endrikat

  KEYWORDS: Bleeding Pattern; Tolerance; Drospirenone; Oral Contraception

  JOURNAL NAME: Health, Vol.5 No.7D, July 10, 2013

  ABSTRACT: Aim: We assessed bleeding pattern, tolerance and patient satisfaction of an oral contraceptive containing 3 mg drospirenone and 30 mcg ethinyl estradiol (DRSP/EE) under real-life conditions. Study Design: We performed a multicenter, prospective, 6-cycle, observational study in Canada, Europe and the Middle East. Detailed analyses of the three Middle East countries, Jordan, Lebanon andSyriawere presented here. The efficacy variables included an assessment of bleeding patterns, premenstrual symptoms of water retention and patient satisfaction, as determined by a visual analogue scale. Results: A total of 914 women were enrolled. The percentage of women with intermenstrual bleeding decreased from 37.4%, 48.7% and 32.2% at baseline to 9.7%, 6.1% and 10.9% at the end of cycle6 inJordan, Lebanon and Syria, respectively (creased sharply in all three countries (p Amenorrhea decreased significantly in Lebanon and Syria (p